BONE BIOLOGICS CORPORATION
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 309.4% | 309.4% | -3,690.9% |
| FY2017 | 84.0% | 84.0% | -886.3% |
| FY2018 | 51.5% | 51.5% | -425.7% |
| FY2019 | 28.9% | 28.9% | -11,109.8% |
| FY2020 | 13.3% | 13.3% | — |
| FY2021 | -24.5% | -24.5% | -24.1% |
| FY2022 | -25.0% | -25.0% | -17.5% |
| FY2023 | -307.9% | -307.9% | -239.4% |
| FY2024 | -118.0% | -118.0% | -106.5% |
| FY2025 | -57.8% | -57.8% | -53.6% |